114 related articles for article (PubMed ID: 34017101)
1. Bridging international approaches on nanoEHS.
Scott-Fordsmand JJ; Amorim MJB; de Garidel-Thoron C; Castranova V; Hardy B; Linkov I; Feitshans I; Nichols G; Petersen EJ; Spurgeon D; Tinkle S; Vogel U; Westerhoff P; Wiesner MR; Hendren CO
Nat Nanotechnol; 2021 Jun; 16(6):608-611. PubMed ID: 34017101
[No Abstract] [Full Text] [Related]
2. Fifteen years of nanoEHS research advances science and fosters a vibrant community.
Friedersdorf LE; Bjorkland R; Klaper RD; Sayes CM; Wiesner MR
Nat Nanotechnol; 2019 Nov; 14(11):996-998. PubMed ID: 31695147
[No Abstract] [Full Text] [Related]
3. The JRC Nanomaterials Repository: A unique facility providing representative test materials for nanoEHS research.
Totaro S; Cotogno G; Rasmussen K; Pianella F; Roncaglia M; Olsson H; Riego Sintes JM; Crutzen HP
Regul Toxicol Pharmacol; 2016 Nov; 81():334-340. PubMed ID: 27670079
[TBL] [Abstract][Full Text] [Related]
4. A functional assay-based strategy for nanomaterial risk forecasting.
Hendren CO; Lowry GV; Unrine JM; Wiesner MR
Sci Total Environ; 2015 Dec; 536():1029-1037. PubMed ID: 26188653
[TBL] [Abstract][Full Text] [Related]
5. Key focal areas for bridging the fields of aging and disability: findings from the growing older with a disability conference.
Naidoo V; Putnam M; Spindel A
Int J Integr Care; 2012 Oct; 12():e201. PubMed ID: 23593057
[TBL] [Abstract][Full Text] [Related]
6. Consistency assessment with global and bridging development strategies in emerging markets.
Li G; Chen J; Quan H; Shentu Y
Contemp Clin Trials; 2013 Nov; 36(2):687-96. PubMed ID: 23702264
[TBL] [Abstract][Full Text] [Related]
7. Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.
van der Pol S; Jacobs MS; Meijer K; Piersma-Wichers MG; Tieleman RG; Postma MJ; van Hulst M
Europace; 2019 May; 21(5):716-723. PubMed ID: 30649301
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian noninferiority approach to evaluation of bridging studies.
Liu JP; Hsueh H; Hsiao CF
J Biopharm Stat; 2004 May; 14(2):291-300. PubMed ID: 15206527
[TBL] [Abstract][Full Text] [Related]
9. [International collaborative trial: from the viewpoints of statistics and data management].
Ohashi Y
Gan To Kagaku Ryoho; 2007 Feb; 34(2):312-5. PubMed ID: 17301552
[TBL] [Abstract][Full Text] [Related]
10. A note on two approaches of testing bridging evidence to a new region.
Dong X; Guo Y; Tsong Y
J Biopharm Stat; 2012 Sep; 22(5):966-76. PubMed ID: 22946943
[TBL] [Abstract][Full Text] [Related]
11. Assessing sensitivity and similarity in bridging studies.
Chow SC; Shao J; Hu OY
J Biopharm Stat; 2002 Aug; 12(3):385-400. PubMed ID: 12448579
[TBL] [Abstract][Full Text] [Related]
12. Bridging international relations and disaster studies: the case of disaster-conflict scholarship.
Hollis S
Disasters; 2018 Jan; 42(1):19-40. PubMed ID: 28452162
[TBL] [Abstract][Full Text] [Related]
13. Attending a bridging program to obtain a Swedish nursing license: An interview study with internationally educated nurses.
Högstedt D; Engström M; Jansson I; Eriksson E
Nurse Educ Today; 2021 Apr; 99():104744. PubMed ID: 33549959
[TBL] [Abstract][Full Text] [Related]
14. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
Pappas MA; Barnes GD; Vijan S
J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
[TBL] [Abstract][Full Text] [Related]
15. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.
Moruf A; Spyropoulos AC; Schardt TQ; Gibson E; Manco-Johnson MJ; Wang M; Goldenberg NA
Thromb Res; 2012 Oct; 130(4):612-5. PubMed ID: 22749329
[TBL] [Abstract][Full Text] [Related]
16. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
17. Bridging for an isolated subtherapeutic INR: an evaluation of clinical practice patterns, outcomes, and costs from an anticoagulation clinic.
Hwang JM; Taylor TN; Sharma KP; Clemente JL; Garwood CL
J Thromb Thrombolysis; 2012 Jan; 33(1):28-37. PubMed ID: 21960323
[TBL] [Abstract][Full Text] [Related]
18. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
19. [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
Schellong SM; Riess H; Spannagl M; Omran H; Schwarzbach M; Langer F; Gogarten W; Bramlage P; Bauersachs RM
Internist (Berl); 2018 Jul; 59(7):744-752. PubMed ID: 29946874
[TBL] [Abstract][Full Text] [Related]
20. Design and analysis of bridging studies with prior probabilities on the null and alternative hypotheses.
Zeng D; Pan Z; Lin DY
Biometrics; 2020 Mar; 76(1):224-234. PubMed ID: 31724739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
